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Extended-spectrum β-lactamases (ESBL) confer resistance to third-generation cephalosporins. ESBL-producing bacteria are a major public health issue, as third-generation cephalosporins are considered by the WHO to be highest-priority critically important antimicrobials ([@B1]). These bacteria can be transmitted from animals to humans via contaminated food products or contact with food-producing animals ([@B2]). Dissemination of ESBL-producing bacteria mainly occurs by the transfer of plasmids of different incompatibility groups ([@B3]) but also vertically via clonal spread ([@B4], [@B5]). In contrast to humans, where CTX-M-15 is the dominant ESBL type, CTX-M-1 is most common type in livestock ([@B6], [@B7]).

To support efficient risk management strategies for the control of ESBL-producing bacteria in food-producing animals and food, the genetic basis of selected commensal *Escherichia coli* strains from the German national monitoring program for antimicrobial resistance in zoonotic agents in the food chain was investigated by the National Reference Laboratory for Antimicrobial Resistance (NRL-AR).

In this study, the genome sequence of the *E. coli* isolate 15-AB01393, recovered from German beef, was determined. This isolate exhibits a non-wild-type phenotype for ampicillin (MIC, \>64 mg/liter), azithromycin (MIC, 64 mg/liter), sulfamethoxazole (MIC, \>1,024 mg/liter), cefepime (MIC, 32 mg/liter), ceftazidime (MIC, 2 mg/liter), and cefotaxime (MIC, 64 mg/liter) using the microdilution method, according to CLSI guidelines ([@B8]), using EUCAST epidemiological cutoff values (<http://www.eucast.org/clinical_breakpoints/>). A single colony from MacConkey agar with 1 mg/liter cefotaxime was cultured in lysogeny broth for 24 h at 37°C. Genomic DNA was isolated from the liquid culture using the PureLink genomic DNA minikit (Invitrogen, Carlsbad, CA, USA) and used for the generation of a Nextera XT library (Illumina, CA, USA). Genome sequencing of 2 × 250-bp paired-end reads was conducted on an in-house Illumina MiSeq sequencing platform ([@B9]). A *de novo* genome assembly (total genome length, 5,055,005 bp; *N*~50~ contig length, 59,668 bp) was performed using SPAdes (version 3.5.0) of the PATRIC database ([@B10]), resulting in 279 contigs with \>25-fold sequence coverage per consensus base. Genome analysis using Web-based tools of the Center for Genomic Epidemiology (<https://cge.cbs.dtu.dk/services/>) revealed that the *E. coli* isolate belongs to the multilocus sequence type (MLST; Achtman scheme) ST58 (clonal complex 155 \[CC155\]) (MLST 1.8) ([@B11]) and harbors genes (*wzt*, *wzm*, and *fliC*) specific for the O8:H25 serotype (SerotypeFinder 1.1) ([@B12]) and the FimH-type determinant *fimH32* (FimTyper 1.0; <https://cge.cbs.dtu.dk/services/FimTyper-1.0/>). Furthermore, ResFinder 3.0 analysis ([@B13], [@B14]) revealed the presence of the resistance genes *bla*~CTX-M-1~ (β-lactam), *mph*(A) (macrolide, lincosamide, and streptogramin B), *sul2* (sulfonamide), *dfrA5* (trimethoprim), and the aminoglycoside determinants *strA* and *strB*. Additionally, several nucleotide variations in the *ampC*, *gyrB*, *parC*, *pmrB*, 16S *rrsB*, 16S *rrsC*, 16S *rrsH*, and 23S genes were detected, which may also contribute to the observed antimicrobial resistance phenotype. Initial genome annotation using the NCBI Prokaryotic Genome Annotation Pipeline (released 2013) ([@B15]) resulted in the detection of 5,453 genes, 19 rRNAs (5S, 16S, and 23S), 83 tRNAs, 9 noncoding RNAs (ncRNAs), 167 pseudogenes, and 2 clustered regularly interspaced short palindromic repeat (CRISPR) arrays. Bioinformatically, four contigs were identified harboring conserved target sequences of the plasmid-based incompatibility groups IncX1 (98.66%), IncQ1 (100%), IncFII (100%), and IncFIB (AP001918) (98.39%) (PlasmidFinder 1.3) ([@B16]). Further examinations are planned to determine the impact of the isolate for the distribution of the resistance genes.
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The whole-genome sequence of *E. coli* isolate 15-AB01393 was deposited in GenBank under the accession number [PEAV00000000](https://www.ncbi.nlm.nih.gov/nuccore/PEAV00000000).
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